A Study to Assess the Efficacy and Safety of a Subcutaneous Formulation of Efgartigimod PH20 SC in Adults With Pemphigus (Vulgaris or Foliaceus)

NCT04598451 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

222

Enrollment

INDUSTRY

Sponsor class

Conditions

Pemphigus Vulgaris
Pemphigus Foliaceus

Interventions

BIOLOGICAL: efgartigimod PH20 SC
OTHER: Placebo
DRUG: prednisone

Sponsor

argenx